Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2-metastatic breast cancer administered abemaciclib plus pembrolizumab Meeting Abstract
| Authors: | Tolaney, S. M.; Kabos, P.; Dickler, M. N.; Gianni, L.; Jansen, V.; Lu, Y.; Young, S.; Rugo, H. S. |
| Abstract Title: | Updated efficacy, safety, & PD-L1 status of patients with HR+, HER2-metastatic breast cancer administered abemaciclib plus pembrolizumab |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 48s |
| Language: | English |
| ACCESSION: | WOS:000442916001081 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.1059 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1059 -- Source: Wos |
